drugset

drugset / Trial / NCT03389191

A Clinical Trial of Acyclovir for Viral Uveitis

NCT03389191 ↗

Unknown 30 enrolled Xiaomin Zhang

NaSingle-groupOpen-labelTreatment

Summary

This project is designed to test the hypothesis that acyclovir is clinically useful for patients with refractory viral uveitis.

Timeline

Start: 2017-01
Primary completion: 2019-12
Completion: 2021-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Acyclovir	Small molecule	100 mg	Oral

Indications